相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Molecular mechanisms underlying the role of microRNAs (miRNAs) in anticancer drug resistance and implications for clinical practice
Elisa Giovannetti et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2012)
The miR-302-367 cluster as a potential stemness regulator in ESCs
Alicia Barroso-del Jesus et al.
CELL CYCLE (2011)
Down-regulated miR-331-5p and miR-27a are associated with chemotherapy resistance and relapse in leukaemia
Dan-Dan Feng et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
Coexpression of an intronic microRNA and its host gene reveals a potential role for miR-483-5p as an IGF2 partner
Ning Ma et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2011)
microRNAs in kidneys: biogenesis, regulation, and pathophysiological roles
Kirti Bhatt et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2011)
Nephroblastoma is a Success of Paediatric Oncologic Therapy. How Further Can We Go?: Results of a Cyto-histologic Correlation Study
Helena Barroca
DIAGNOSTIC CYTOPATHOLOGY (2010)
Implication of microRNAs in drug resistance for designing novel cancer therapy
Fazlul H. Sarkar et al.
DRUG RESISTANCE UPDATES (2010)
Role of microRNA in anticancer drug resistance
Tongsen Zheng et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Resistance May Not Be Futile: microRNA Biomarkers for Chemoresistance and Potential Therapeutics
Kristi E. Allen et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Identification of the miR-106b∼25 MicroRNA Cluster as a Proto-Oncogenic PTEN-Targeting Intron That Cooperates with Its Host Gene MCM7 in Transformation
Laura Poliseno et al.
SCIENCE SIGNALING (2010)
MicroRNAs and the kidney: coming of age
Samuel Saal et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2009)
Epigenetic Alterations in Cholangiocarcinoma-Sustained IL-6/STAT3 Signaling in Cholangiocarcinoma due to SOCS3 Epigenetic Silencing
Hajime Isomoto
DIGESTION (2009)
E2F1-regulated microRNAs impair TGFβ-dependent cell-cycle arrest and apoptosis in gastric cancer
Fabio Petrocca et al.
CANCER CELL (2008)
miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells
Lin Xia et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
MicroRNA-221/222 Negatively Regulates Estrogen Receptor α and Is Associated with Tamoxifen Resistance in Breast Cancer
Jian-Jun Zhao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1
Tyler E. Miller et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression
Irena Ivanovska et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Oct4/Sox2-regulated miR-302 targets cyclin D1 in human embryonic stem cells
Deborah A. Greer Card et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Epigenetic specificity of loss of imprinting of the IGF2 gene in Wilms tumors
Hans T. Bjornsson et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
A mammalian microRNA expression atlas based on small RNA library sequencing
Pablo Landgraf et al.
CELL (2007)
MicroRNA expression profiles for the NCI-60 cancer cell panel
Paul E. Blower et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Expression profiling of Wilms tumors reveals new candidate genes for different clinical parameters
B Zirn et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Wilms' tumour: Connecting tumorigenesis and organ development in the kidney
MN Rivera et al.
NATURE REVIEWS CANCER (2005)
Human embryonic stem cells express a unique set of microRNAs
MR Suh et al.
DEVELOPMENTAL BIOLOGY (2004)
Reduction of postoperative chemotherapy in children with stage I intermediate-risk and anaplastic Wilms' tumour (SIOP 93-01 trial): a randomised controlled trial
J de Kraker et al.
LANCET (2004)
The role of preoperative chemotherapy in the management of Wilms' tumor - The SIOP studies
N Graf et al.
UROLOGIC CLINICS OF NORTH AMERICA (2000)
分享论文
